Atai stocks.

Feb 9, 2023 · 1. ATAI Life Sciences. The financial services firm H.C. Wainwright & Co. recently issued a $20 price target on ATAI Life Sciences (NASDAQ: ATAI) stock. This 12-month price target implies an upside ... Find the latest Atari SA (ALATA.PA) stock quote, history, news and other vital information to help you with your stock trading and investing. Shares of mental health biopharma Atai Life Sciences N.V. have fallen some two-thirds from their June 2021 IPO pricing as the biotech market continues to crater. See why ATAI stock is a buy.At Compass’ current market cap of ~$1.1 billion, ATAI has a $200 – 300 million stake in the company. This gives ATAI’s valuation a sort of floor dependent on Compass’ ultimate market cap. It will be just as important for Compass to succeed over the coming months as it will for ATAI’s portfolio companies to perform.WebAccording to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,105.36% from the …

ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ...Atai Life Sciences Stock Forecast All Analysts Top Analysts ATAI's stock price has decreased by -55.17% in the past year and price targets may not have had …Can ATAI Life Sciences N.V. (NASDAQ: ATAI) Still Be Considered A Loss When It’s Down -57.89% YTD? Marketing Sentinel about 20 hours ago ATAI Life Sciences NV Reports Qâ â â ¦â â Financial Results and Pipeline Progress GuruFocus 16 days ago Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026 …Web

The latest price target for ATAI Life Sciences (NASDAQ: ATAI) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price ...

Get the latest Atai Life Sciences N.V. (ATAI) stock news and headlines to help you in your trading and investing decisions.Atai Life Sciences (NASDAQ:ATAI) said its majority-owned unit Perception Neuroscience's therapy PCN-101 (R-ketamine) did not meet the main goal of a phase 2a trial for treatment-resistant depression.According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).ATAI stock recorded 10/30 (33%) green days with 6.79% price …

Sarah Popham. Linked companies : Atai Life Sciences N.V. Summary. Presently, Sarah Popham is Vice President-Regulatory Affairs for ATAI Life Sciences NV. She received an undergraduate degree from the University of Bradford. Current …Web

PONGF | Complete Atari S.A.S. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

1.47M. 111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... Contact Email [email protected]. Phone Number +49 (0) 89 2153 9035. ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that ...WebView the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Atai Capital highlighted stocks like Alphabet Inc. (NASDAQ:GOOG) in the Q3 2023 investor letter. Headquartered in Mountain View, California, Alphabet Inc. (NASDAQ:GOOG) is a multinational ...Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the ...In January 2023, atai announced results from the Phase 2a proof-of-concept study evaluating a single IV administration of PCN-101 in patients with treatment-resistant depression across three arms ...

Fundamentals ATAI LIFE SCIENCES BV EO1. Dividend. Dividend yield in %. P/E Ratio, -1.17. Profit per share, -0.84. Number of shares, 165.94 m. Market ...ATAI stock closed at $1.12 and is down -$0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a poor overall score of 33 meaning the stock holds a better value than just 33% of stocks at its current price.Mar 6, 2023 · In January, Atai's majority-owned unit Perception Neuroscience's therapy PCN-101 (R-ketamine) did not meet the main goal of a phase 2a trial in treatment-resistant depression which sent the stock ... Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...See Full ATAI Report. ATAI stock closed at $1.12 and is down -$0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower …ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ...On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the ...

Atari (/ ə ˈ t ɑːr i /) is a brand name that has been owned by several entities since its inception in 1972.It is currently owned by French company Atari SA (formerly Infogrames) through a subsidiary named Atari Interactive. The original Atari, Inc., founded in Sunnyvale, California, USA in 1972 by Nolan Bushnell and Ted Dabney, was a pioneer in arcade …WebAtai Life Sciences (ATAI 7.69%) is approaching psychedelic therapy development from the perspective of a venture capital investor. Each program in its pipeline is managed by a separate company ...

Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!Mar 6, 2023 · In January, Atai's majority-owned unit Perception Neuroscience's therapy PCN-101 (R-ketamine) did not meet the main goal of a phase 2a trial in treatment-resistant depression which sent the stock ... Atai Life Sciences (ATAI 7.69%) is approaching psychedelic therapy development from the perspective of a venture capital investor. Each program in its pipeline is managed by a separate company ...Over the past 12 months, ATAI’s stock has witnessed a remarkable growth rate of 631.38%. Despite its impressive performance in the stock market, ATAI has faced its fair share of challenges since ...Nov 29, 2023 · The average trading volume of ATAI on November 29, 2023 was 536.92K shares. ATAI) stock’s latest price update. The stock price of ATAI Life Sciences N.V. (NASDAQ: ATAI) has plunged by -3.51 when compared to previous closing price of 1.14, but the company has seen a 2.80% gain in its stock price over the last five trading sessions. Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsKey Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $-0.42 · Market Cap. $185.93 M · Shares Outstanding. 166.01 M · Public Float. 114.08 M · Yield. ATAI is not ...Feb 9, 2023 · 1. ATAI Life Sciences. The financial services firm H.C. Wainwright & Co. recently issued a $20 price target on ATAI Life Sciences (ATAI 7.69%) stock. This 12-month price target implies an upside ... Meanwhile, Atai listed on the Nasdaq in June, raising $225 million at a valuation of $2.3 billion. The stock immediately popped 40% but it has since halved in value and Atai's current market cap ...

With its shares down by 60% in the last 12 months and a recent layoff affecting 30% of its workforce, it's fair to say that Atai Life Sciences ( ATAI 1.87%) is having a rough go of things lately ...

atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights. Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and data from the EMP-01 (MDMA derivative) Phase 1 study is anticipated to report out later this year. Phase 1 data of VLS-01 (a proprietary oral transmucosal film ...

Jan 17, 2023 · Atai Life Sciences (NASDAQ: ATAI) is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. In the first week of the new year, the stock plummeted when the failed results of ATAI's NYC-based subsidiary, Perception Neuroscience's Phase 2a study of proprietary R-ketamine PCN-101 on patients with ... Nov 14, 2023 · Clinical-stage psychedelics company atai Life Sciences (NASDAQ: ATAI) reported its financial results and corporate updates for the third quarter ended September 30, 2023. In numbers: Atai Capital experienced a decline of 5.8% in the third quarter, bringing our year-to-date (YTD) returns to 6.5% net of all fees. This compares to a 13.1% total return for the S&P 500 YTD and a 2. ...View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Contact Email [email protected]. Phone Number +49 (0) 89 2153 9035. ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that ...WebThe ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks Dividend yield The ratio of annual dividend to current …View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.ATAI Stock Price Today by TradingView. Atai Life Sciences (NASDAQ: ATAI) is “a biopharmaceutical company that leverages a decentralized platform approach to incubate and accelerate the development of highly effective mental health treatments.” Like many companies on this list, they are working on treatments for mental health issues like ...ATAI Life Sciences is a biopharmaceutical company focused on developing psychedelic-based treatments for mental health conditions. The company has a diverse portfolio of drug candidates in various ...Real time Atai Life Sciences (ATAI) stock price quote, stock graph, news & analysis.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights. Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and data from the EMP-01 (MDMA derivative) Phase 1 study is anticipated to report out later this year. Phase 1 data of VLS-01 (a proprietary oral transmucosal film ...

As of last trade ATAI Life Sciences NV (ATAI:NMQ) traded at 1.10, 4.76% above its 52-week low of 1.05, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Nov 30 2023 18:35 GMT. Latest ATAI Life Sciences NV (ATAI:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and …The stock had already been climbing after its fourth-quarter and full-year report was released on March 24, but a spate of inside buying on Wednesday by Atai co-founder and chairman Christian ...In January 2023, atai announced results from the Phase 2a proof-of-concept study evaluating a single IV administration of PCN-101 in patients with treatment-resistant depression across three arms ...Research Atai Life Sciences' (Nasdaq:ATAI) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...Instagram:https://instagram. options alert serviceno w2 mortgage loangulahmed pkamazon stock forecast 2023 See Full ATAI Report. ATAI stock closed at $1.12 and is down -$0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower … pffaalphabet stock dividend View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Mar 27, 2023 · 0. These 7 analysts have an average price target of $13.29 versus the current price of ATAI Life Sciences at $1.3447, implying upside. Below is a summary of how these 7 analysts rated ATAI Life ... best farmland reits ATAI Life Sciences (ATAI) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. …ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low. So far 597,235 shares have traded compared to average volume of 1,159,249 shares. Click Here to get the ...